Stay ahead of the logs with our Monday Recap. We break down active Adobe 0-days, North Korean crypto stings, and critical CVEs you need to patch today ...

A budding interest in tuning his own car meshed perfectly with Geglia’s background in computer programming. Vince Geglia II’s break came via the Chevrolet Cobalt. Not the Cobalt SS, but the base ...

A group of Buddhist monks, accompanied by their loyal dog, Aloka, are walking across multiple states as part of a Walk for Peace and have arrived in North Carolina. The group started their 2,300-mile ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

Vibe coding tools like Anthropic's Claude Code are flooding software with new vulnerabilities, Georgia Tech researchers have warned. At least 35 new common vulnerabilities and exposures (CVE) entries ...

Iran's de facto blockade of the Strait of Hormuz has squeezed shipping traffic to a trickle since the war began. A small number of other ships have made the crossing, signaling that Tehran is ...

Drivers on the Route 30/222 interchange in Lancaster County are seeing a lot of delays right now due to construction. Heavy snow warning as 11 inches could drop Why Congress keeps handing Trump its ...

Charting the course of racing history, officials today unveiled the unique racetrack design and layout for this summer’s Freedom 250 Grand Prix of Washington, D.C., featuring the cars and stars of the ...

Predictions that AI tools could help displace established business software are quietly coming true in some segments of the market. A number of small and midsize companies say they are vibe coding ...

An MCP (Model Context Protocol) server for tracking Claude Code usage costs across all your projects. Built for developers who want to monitor and analyze their AI development costs with precision.

Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...